The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease

Functional Neurology

Volumn 16, Issue 4 SUPPL., 2001, Pages 99-106

  Blandini, Fabio ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Basal ganglia; Dopamine; Glutamate; Movement disorders; Neuroprotection; Substantia nigra

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; DOPAMINE; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT;

BASAL GANGLION; CONFERENCE PAPER; DOPAMINERGIC ACTIVITY; EXPERIMENTAL MODEL; HUMAN; MOTOR DYSFUNCTION; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL NETWORK; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; ANIMAL; DRUG EFFECT; NERVE DEGENERATION; NERVE TRACT; REVIEW;

ANIMALS; BASAL GANGLIA; HUMANS; NERVE DEGENERATION; NEURAL PATHWAYS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 0035544924     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Functional changes of the basal ganglia circuitry in Parkinson's disease
2. The functional anatomy of basal ganglia disorders
3. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing
4. Functional metabolic mapping of the rat brain during unilateral electrical stimulation of the subthalamic nucleus
5. Effect of subthalamic nucleus lesion on mitochondrial enzyme activity in rat basal ganglia
6. Autoradiographic study of mitochondrial complex I and glutamate receptors in the basal ganglia of rats after unilateral subthalamic lesion
7. Microcircuitry of the direct and indirect pathways of the basal ganglia
8. Extrastriatal dopaminergic innervation of human basal ganglia
9. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat
10. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus
11. Six-hydroxydopamine induced degeneration of central monoamine neurons
12. Primate models of movement disorders of basal ganglia origin
13. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism
14. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease
15. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkey exposed to 1-methyl-4 phenyl 1,2,3,6-tetrahydropyridine
16. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion
17. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study
18. Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons
19. Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats
20. Contralateral disappearance of parkinsonian signs after subthalamotomic hematoma
21. Dopamine/glutamate interactions in Parkinson's disease
22. Chronic intracerebral stimulation in Parkinson's disease
23. Mechanism of action of deep brain stimulation
24. Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats
25. Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease
26. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinihibition via the globus pallidus
27. The D1 dopamine receptor in the rat brain: Quantitative autoradiographic localization using an iodinated ligand
28. Expression of dopamine receptors in the subthalamic nucleus of the rat: Characterization using reverse transcriptase-polymerase chain reaction and autoradiography
29. Apomorphine and dopamine D1 receptor agonists increase the firing rate of subthalamic nucleus neurons
30. Effects of intrasubtahalmic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: An electrophysiological and c-Fos study
31. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats
32. Increased [I125] sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions
33. Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients
34. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions
35. Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants
36. Synaptic innervation of mid-brain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey
37. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity
38. Oxidative stress, glutamate, and neurodegenerative disorders
39. Glutamate triggers internucleosomal DNA cleavage in neuronal cells
40. Oxidative stress induces a form of programmed cell death with characteristics of bptj apoptosis and necrosis in neuronal cells
41. Glutamate and the pathophysiology of hypoxic-ischemic brain damage
42. Alternative excitotoxic hypotheses
43. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative disease?
44. Mitochondrial complex I deficiency in Parkinson's disease
45. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection
46. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: Behavioural and immunohistochemical studies
47. Prevention of transneuronal degeneration of neurons in the substantia nigra reticulata by ablation of the subthalamic nucleus
48. Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid
49. The role of glutamate in the pathophysiology of Parkinson's disease
50. Prospects of glutamate antagonists in the therapy of Parkinso's disease